Recently visited
Please sign in to see a list of articles you recently visited.
Recently updated
• HNF4A
Homo sapiens
• NFE2L2
Homo sapiens
• SPI1
Homo sapiens
• ATF2
Homo sapiens
• LMX1A
Homo sapiens
• Nr2e1
Mus musculus
• NR2E1
Homo sapiens
• EPAS1
Homo sapiens
• SNAI2
Homo sapiens
Transcription Factor Encyclopedia  BETA
Sign in or sign up.
Pages
AboutArticlesBrowseClassificationSearchAuthorsFeedbackCitationAPI
SummaryStructureTFBSTargetsProteinInteractionsGeneticsExpressionOntologiesPapers
view contentcomments
Download article (PDF)    Download data (Excel)   View recent activity
Comments (post)
There are no comments posted here... Yet.
Gene Ontology (automatically populated)
Tree viewTable view
molecular_function (GO:0003674)
binding (GO:0005488)
nucleic acid binding (GO:0003676)
 DNA binding (GO:0003677) 
 sequence-specific DNA binding (GO:0043565) 
 protein binding (GO:0005515) 
ion binding (GO:0043167)
cation binding (GO:0043169)
transition metal ion binding (GO:0046914)
 zinc ion binding (GO:0008270) 
 metal ion binding (GO:0046872) 
transcription regulator activity (GO:0030528)
 transcription factor activity (GO:0003700) 
 transcription activator activity (GO:0016563) 
molecular transducer activity (GO:0060089)
signal transducer activity (GO:0004871)
receptor activity (GO:0004872)
ligand-dependent nuclear receptor activity (GO:0004879)
 steroid hormone receptor activity (GO:0003707) 
 retinoic acid receptor activity (GO:0003708) 
 cellular_component (GO:0005575) 
organelle (GO:0043226)
membrane-bounded organelle (GO:0043227)
intracellular membrane-bounded organelle (GO:0043231)
 nucleus (GO:0005634) 
cell part (GO:0044464)
intracellular part (GO:0044424)
 cytoplasm (GO:0005737) 
biological_process (GO:0008150)
cellular process (GO:0009987)
cell communication (GO:0007154)
 signal transduction (GO:0007165) 
cell development (GO:0048468)
 neurogenesis (GO:0022008) 
cellular developmental process (GO:0048869)
cell differentiation (GO:0030154)
cardiac cell differentiation (GO:0035051)
cardiac muscle cell differentiation (GO:0055007)
 ventricular cardiac muscle cell differentiation (GO:0055012) 
developmental process (GO:0032502)
anatomical structure morphogenesis (GO:0009653)
organ morphogenesis (GO:0009887)
embryonic organ morphogenesis (GO:0048562)
 embryonic eye morphogenesis (GO:0048048) 
appendage morphogenesis (GO:0035107)
limb morphogenesis (GO:0035108)
embryonic limb morphogenesis (GO:0030326)
 embryonic hindlimb morphogenesis (GO:0035116) 
anatomical structure development (GO:0048856)
 ureteric bud development (GO:0001657) 
 striatum development (GO:0021756) 
biological regulation (GO:0065007)
regulation of biological process (GO:0050789)
positive regulation of biological process (GO:0048518)
positive regulation of cellular process (GO:0048522)
positive regulation of programmed cell death (GO:0043068)
 positive regulation of apoptosis (GO:0043065) 
negative regulation of biological process (GO:0048519)
negative regulation of cellular process (GO:0048523)
 negative regulation of cell proliferation (GO:0008285) 
regulation of cellular process (GO:0050794)
regulation of gene expression (GO:0010468)
regulation of transcription (GO:0045449)
 regulation of transcription, DNA-dependent (GO:0006355) 
negative regulation of transcription, DNA-dependent (GO:0045892)
 negative regulation of transcription from RNA polymerase II promoter (GO:0000122) 
positive regulation of transcription, DNA-dependent (GO:0045893)
 positive regulation of transcription from RNA polymerase II promoter (GO:0045944) 
 CategoryGO term IDTermEvidencePubmed
1BPGO:0048048embryonic eye morphogenesisIEA(none)
2BPGO:0035116embryonic hindlimb morphogenesisIEA(none)
3BPGO:0008285negative regulation of cell proliferationIEA(none)
4BPGO:0000122negative regulation of transcription from RNA polymerase II promoterIEA(none)
5BPGO:0022008neurogenesisIEA(none)
6BPGO:0043065positive regulation of apoptosisIEA(none)
7BPGO:0045944positive regulation of transcription from RNA polymerase II promoterIEA(none)
8BPGO:0006355regulation of transcription, DNA-dependentIEA(none)
9BPGO:0007165signal transductionTAS2833708
10BPGO:0021756striatum developmentIEA(none)
11BPGO:0001657ureteric bud developmentIEA(none)
12BPGO:0055012ventricular cardiac muscle cell differentiationIEA(none)
13CCGO:0005575cellular_componentND(none)
14CCGO:0005737cytoplasmIEA(none)
15CCGO:0005634nucleusIEA(none)
16MFGO:0003677DNA bindingTAS2153268
17MFGO:0046872metal ion bindingIEA(none)
18MFGO:0005515protein bindingIPI19345331
19MFGO:0003708retinoic acid receptor activityIEA(none)
20MFGO:0043565sequence-specific DNA bindingIEA(none)
21MFGO:0003707steroid hormone receptor activityIEA(none)
22MFGO:0016563transcription activator activityIEA(none)
23MFGO:0003700transcription factor activityIEA(none)
24MFGO:0008270zinc ion bindingIEA(none)
MeSH cloud (automatically populated)
Key terms All terms Cloud
About this section
The MeSH cloud below displays MeSH terms that are associated with this transcription factor. The physical size of the terms reflect the significance of their association with the transcription factor as determined by the Fisher's Exact Test. It should be noted that these associations do not necessarily imply a positive correlation between the described MeSH term and this transcription factor. For instance, if the MeSH term "apoptosis" occurs, it may indicate that this transcription factor can induce apoptosis (positive correlation), or prevent apoptosis (negative correlation). Methods: The transcription factor is mapped to a set of Pubmed publications through the gene-to-pubmed association as provided by NCBI. Then, a collection of MeSH terms associated with the papers are compiled, along with the frequency of each MeSH term. The Fisher's Exact Test is conducted on the frequency of each term in the collection, versus its average frequency, to determine its significance in the collection. More information on MeSH can be found on the MeSH homepage.
MeSH term Fisher's exact p-value
1 DNA Methylation 1.2 x 10-78
2 Tretinoin 7.6 x 10-71
3 Humans 1.3 x 10-18
4 Transcription, Genetic 2.0 x 10-15
5 DNA, Neoplasm 4.4 x 10-14
6 CpG Islands 8.0 x 10-13
7 Reverse Transcriptase Polymerase Chain Reaction 1.1 x 10-11
8 Protein Isoforms 1.2 x 10-11
9 Breast Neoplasms 2.7 x 10-11
10 Chromosomes, Human, Pair 3 6.4 x 10-11
11 Transcriptional Activation 1.8 x 10-10
12 Response Elements 2.1 x 10-10
13 RNA, Neoplasm 2.5 x 10-10
14 Transfection 1.4 x 10-9
15 DNA Primers 1.7 x 10-9
16 Restriction Mapping 2.6 x 10-9
17 Azacitidine 4.9 x 10-9
18 Histones 5.8 x 10-9
19 Receptors, Thyroid Hormone 9.2 x 10-9
20 Carcinoma, Hepatocellular 1.0 x 10-8
21 Histone Deacetylases 2.7 x 10-8
22 Leukemia, Promyelocytic, Acute 3.0 x 10-8
23 Esophageal Neoplasms 3.6 x 10-8
24 Carcinoma, Squamous Cell 4.5 x 10-8
25 Ligands 5.8 x 10-8
26 Core Binding Factor Alpha 2 Subunit 8.3 x 10-8
27 DNA, Complementary 1.0 x 10-7
28 Open Reading Frames 1.0 x 10-7
29 Oncogene Proteins, Fusion 1.4 x 10-7
30 Acetylation 7.1 x 10-7
31 Cell Differentiation 1.0 x 10-6
32 Retinoid X Receptor alpha 1.2 x 10-6
33 Nuclear Receptor Co-Repressor 2 1.2 x 10-6
34 Calcium-Calmodulin-Dependent Protein Kinases 1.5 x 10-6
35 Exons 1.6 x 10-6
36 Nuclear Receptor Subfamily 4, Group A, Member 2 1.9 x 10-6
37 Cyclin-Dependent Kinase Inhibitor p16 2.2 x 10-6
38 Drug Resistance, Neoplasm 2.6 x 10-6
39 Cyclin D2 3.6 x 10-6
40 Retinol-Binding Proteins, Cellular 4.9 x 10-6
41 Fenretinide 6.3 x 10-6
42 Nuclear Receptor Coactivator 1 6.7 x 10-6
43 Homeodomain Proteins 8.1 x 10-6
44 Transcription Factor AP-1 8.2 x 10-6
45 Anticarcinogenic Agents 9.0 x 10-6
46 Apoptosis 9.2 x 10-6
47 Zinc Fingers 1.2 x 10-5
48 Two-Hybrid System Techniques 1.6 x 10-5
49 Receptors, Glucocorticoid 2.1 x 10-5
50 Glutathione S-Transferase pi 2.3 x 10-5
51 Cadherins 3.1 x 10-5
52 Prostatic Neoplasms 5.6 x 10-5
53 Recombinant Fusion Proteins 5.6 x 10-5
54 Protein Binding 6.0 x 10-5
55 DNA (Cytosine-5-)-Methyltransferase 6.1 x 10-5
56 Gene Expression Regulation, Leukemic 6.8 x 10-5
57 p300-CBP Transcription Factors 9.0 x 10-5
58 Hepatitis B virus 0.00010
59 Trans-Activators 0.00011
60 Signal Transduction 0.00017
61 Uterine Cervical Neoplasms 0.00021
62 Lipodystrophy, Familial Partial 0.00025
63 Endometrium 0.00036
64 Biopsy, Fine-Needle 0.00036
65 Proto-Oncogene Proteins c-jun 0.00041
66 Polymorphism, Single Nucleotide 0.00051
67 Thiazolidinediones 0.00064
68 Alleles 0.00066
69 Tumor Suppressor Protein p53 0.00067
70 Heterochromatin 0.00088
71 HL-60 Cells 0.00093
72 COUP Transcription Factor I 0.0012
73 Zebrafish 0.0012
74 Insulin-Like Growth Factor Binding Protein 6 0.0012
75 Growth Differentiation Factor 15 0.0012
76 Down-Regulation 0.0012
77 Genetic Markers 0.0013
78 GATA6 Transcription Factor 0.0014
79 Neoplasm Invasiveness 0.0016
80 Cell Aging 0.0018
81 Sequence Homology, Nucleic Acid 0.0019
82 Up-Regulation 0.0020
83 Gene Expression Profiling 0.0021
84 Karyotyping 0.0021
85 Retinal Pigment Epithelium 0.0023
86 Blotting, Northern 0.0023
87 Antimetabolites, Antineoplastic 0.0023
88 Transcription Factor TFIIIA 0.0025
89 Twist Transcription Factor 0.0025
90 Human papillomavirus 18 0.0026
91 Genome, Human 0.0026
92 Nuclear Receptor Subfamily 4, Group A, Member 1 0.0028
93 Choroid Plexus Neoplasms 0.0029
94 Proteomics 0.0030
95 Kuru 0.0032
96 Teratocarcinoma 0.0034
97 Sp3 Transcription Factor 0.0036
98 Tissue Inhibitor of Metalloproteinase-3 0.0037
99 Microsatellite Instability 0.0039
100 Carcinoma, Small Cell 0.0039
101 Carcinoma, Renal Cell 0.0042
102 Hela Cells 0.0043
103 SOX9 Transcription Factor 0.0045
104 Lamin Type A 0.0047
105 Chalcone 0.0047
106 RNA, Small Interfering 0.0048
107 Genetic Vectors 0.0048
108 Prostatic Intraepithelial Neoplasia 0.0052
109 Progeria 0.0055
110 Contig Mapping 0.0055
111 Mammary Glands, Human 0.0057
112 Receptor, Platelet-Derived Growth Factor alpha 0.0057
113 Adenomatous Polyposis Coli Protein 0.0057
114 Gene Knockdown Techniques 0.0059
115 Interferon Regulatory Factor-1 0.0060
116 Tetrahydronaphthalenes 0.0060
117 Adult Stem Cells 0.0061
118 Von Hippel-Lindau Tumor Suppressor Protein 0.0064
119 Genome-Wide Association Study 0.0065
120 Introns 0.0066
121 Carcinoma, Adenosquamous 0.0067
122 Proto-Oncogene Proteins B-raf 0.0067
123 COS Cells 0.0068
124 Dinucleotide Repeats 0.0069
125 Immunochemistry 0.0071
126 Respiratory Mucosa 0.0074
127 DNA, Viral 0.0078
128 G0 Phase 0.0079
129 Microdissection 0.0079
130 Chondrogenesis 0.0081
131 Carcinoma, Endometrioid 0.0082
132 Tissue Scaffolds 0.0082
133 Ether-A-Go-Go Potassium Channels 0.0082
134 Adenovirus E1A Proteins 0.0083
135 Cluster Analysis 0.0083
136 Prostate 0.0084
137 Genes, Reporter 0.0088
138 Chromatin Assembly and Disassembly 0.0088
139 Thrombomodulin 0.0094
140 Genes, BRCA2 0.010
141 Osteocytes 0.010
142 Genes, jun 0.010
143 Bupropion 0.010
144 Disease Progression 0.010
145 Protein Multimerization 0.010
146 Genes, APC 0.011
147 In Situ Hybridization, Fluorescence 0.011
148 Blast Crisis 0.011
149 Aged, 80 and over 0.012
150 BRCA1 Protein 0.012
151 Receptors, Estrogen 0.013
152 Papua New Guinea 0.013
153 Multigene Family 0.013
154 Benzoates 0.013
155 Genes, bcl-2 0.014
156 Thyroid Neoplasms 0.014
157 Genes, Viral 0.015
158 Carcinoma, Lobular 0.015
159 Endometrial Hyperplasia 0.015
160 Chromosomes, Human, X 0.015
161 STAT1 Transcription Factor 0.016
162 Leukoplakia, Oral 0.016
163 Metaplasia 0.016
164 Chromatin Immunoprecipitation 0.016
165 Organ Specificity 0.016
166 TATA Box 0.016
167 Adaptor Proteins, Vesicular Transport 0.016
168 Aldehyde Dehydrogenase 0.017
169 Esophagus 0.019
170 Genes, BRCA1 0.019
171 Blotting, Western 0.019
172 Sp1 Transcription Factor 0.019
173 U937 Cells 0.022
174 Nicotinic Agonists 0.022
175 Choroid Plexus 0.023
176 Genes, fos 0.023
177 Transglutaminases 0.023
178 Primary Myelofibrosis 0.024
179 Fluorescence Resonance Energy Transfer 0.024
180 Gene Duplication 0.024
181 Oropharyngeal Neoplasms 0.024
182 5' Untranslated Regions 0.025
183 Premenopause 0.026
184 Antidepressive Agents, Second-Generation 0.026
185 Neoplasm Transplantation 0.027
186 Antigens, CD44 0.027
187 Genomic Library 0.027
188 Sulfites 0.027
189 Exonucleases 0.028
190 Mesenchymal Stem Cells 0.028
191 Creutzfeldt-Jakob Syndrome 0.028
192 Cyclin D1 0.028
193 Brain Chemistry 0.029
194 Mutagenesis, Site-Directed 0.029
195 Glutamate Dehydrogenase 0.030
196 Forkhead Transcription Factors 0.030
197 Cyclooxygenase 2 Inhibitors 0.031
198 Tobacco Use Disorder 0.031
199 Phosphatidylserines 0.031
200 Nucleosomes 0.032
201 Glyceraldehyde-3-Phosphate Dehydrogenases 0.032
202 CCAAT-Enhancer-Binding Proteins 0.033
203 Early Diagnosis 0.033
204 Culture Media, Serum-Free 0.034
205 Lac Operon 0.035
206 Proto-Oncogene Proteins c-myc 0.036
207 Databases, Protein 0.037
208 Genetic Predisposition to Disease 0.038
209 Prodrugs 0.038
210 Phenyl Ethers 0.039
211 DNA Topoisomerases, Type II 0.039
212 Telomerase 0.040
213 Thymidine Kinase 0.040
214 Deoxyribonuclease I 0.041
215 Cyclin-Dependent Kinase Inhibitor p21 0.041
216 Lymphatic Metastasis 0.041
217 bcl-2-Associated X Protein 0.042
218 Chondrocytes 0.043
219 Colonic Neoplasms 0.044
220 Telomere 0.045
221 Prions 0.046
222 Ki-67 Antigen 0.048
223 Chemoprevention 0.049
MeSH term Fisher's exact p-value
1 Receptors, Retinoic Acid 0
2 Receptors, Cytoplasmic and Nuclear 6.5 x 10-217
3 Transcription Factors 1.2 x 10-169
4 DNA-Binding Proteins 2.6 x 10-162
5 Retinoids 8.4 x 10-80
6 DNA Methylation 1.2 x 10-78
7 Genetic Phenomena 2.6 x 10-75
8 Carotenoids 2.6 x 10-74
9 Cyclohexenes 1.0 x 10-73
10 Tretinoin 7.6 x 10-71
11 Cyclohexanes 1.8 x 10-67
12 Polyenes 4.0 x 10-67
13 Methylation 2.4 x 10-65
14 Vitamin A 1.2 x 10-63
15 Alkylation 2.7 x 10-62
16 Alkenes 4.3 x 10-61
17 Cycloparaffins 5.8 x 10-61
18 Hydrocarbons, Alicyclic 5.9 x 10-61
19 Genetic Processes 6.7 x 10-61
20 Proteins 8.4 x 10-61
21 Genetic Structures 1.1 x 10-59
22 Pigments, Biological 1.6 x 10-55
23 Hydrocarbons, Acyclic 5.6 x 10-55
24 Amino Acids, Peptides, and Proteins 1.2 x 10-54
25 Gene Components 1.9 x 10-53
26 Tumor Cells, Cultured 2.8 x 10-52
27 Terpenes 5.0 x 10-52
28 Genes 1.1 x 10-51
29 Biochemical Phenomena 8.0 x 10-50
30 Base Sequence 1.6 x 10-49
31 Genome 1.9 x 10-49
32 Genome Components 2.6 x 10-49
33 Promoter Regions, Genetic 4.1 x 10-49
34 Regulatory Sequences, Nucleic Acid 2.0 x 10-48
35 Regulatory Elements, Transcriptional 6.0 x 10-48
36 Gene Expression Regulation 9.2 x 10-47
37 Gene Expression Regulation, Neoplastic 3.5 x 10-44
38 Cells, Cultured 2.3 x 10-43
39 Genetic Techniques 3.8 x 10-43
40 Chemical Phenomena 2.5 x 10-42
41 Molecular Structure 2.8 x 10-42
42 Biochemical Processes 1.0 x 10-41
43 Chemical Processes 2.8 x 10-38
44 Neoplasm Proteins 2.3 x 10-36
45 Neoplasms 6.2 x 10-36
46 Hydrocarbons, Cyclic 2.3 x 10-35
47 Nucleic Acids 3.7 x 10-35
48 Neoplasms by Site 1.2 x 10-34
49 Nucleic Acids, Nucleotides, and Nucleosides 2.3 x 10-34
50 Cell Line, Tumor 1.6 x 10-29
51 Retinoid X Receptors 1.7 x 10-28
52 Hydrocarbons 4.6 x 10-28
53 Metabolism 1.1 x 10-27
54 Metabolic Phenomena 2.1 x 10-27
55 Cell Line 1.0 x 10-26
56 Cells 5.1 x 10-26
57 Gene Silencing 1.8 x 10-24
58 Epigenesis, Genetic 3.5 x 10-24
59 Carcinoma 1.2 x 10-23
60 Biological Factors 1.9 x 10-23
61 Nuclear Proteins 2.6 x 10-22
62 Neoplasms, Glandular and Epithelial 2.8 x 10-22
63 Molecular Sequence Data 7.1 x 10-21
64 DNA 9.5 x 10-21
65 Documentation 3.3 x 10-20
66 Neoplasms by Histologic Type 5.5 x 10-20
67 Information Services 1.5 x 10-19
68 Genes, Neoplasm 5.9 x 10-19
69 Humans 1.3 x 10-18
70 Hominidae 1.3 x 10-18
71 Gene Expression 1.6 x 10-18
72 Catarrhini 2.3 x 10-18
73 Haplorhini 2.8 x 10-18
74 Primates 2.9 x 10-18
75 Cell Physiological Processes 5.2 x 10-18
76 RNA 5.9 x 10-18
77 Oncogene Proteins 1.6 x 10-17
78 Laboratory Chemicals 1.4 x 10-16
79 Genes, Tumor Suppressor 1.5 x 10-16
80 Carrier Proteins 2.2 x 10-16
81 RNA, Messenger 4.5 x 10-16
82 Nucleic Acid Probes 1.5 x 10-15
83 DNA Probes 1.8 x 10-15
84 Transcription, Genetic 2.0 x 10-15
85 Molecular Probes 2.2 x 10-15
86 Cell Physiological Phenomena 3.9 x 10-15
87 Tumor Suppressor Proteins 5.3 x 10-15
88 Genes, Recessive 5.5 x 10-15
89 Cloning, Molecular 2.4 x 10-14
90 Polymerase Chain Reaction 3.0 x 10-14
91 Nucleic Acid Amplification Techniques 3.6 x 10-14
92 DNA, Neoplasm 4.4 x 10-14
93 CpG Islands 8.0 x 10-13
94 GC Rich Sequence 1.3 x 10-12
95 Antineoplastic Agents 1.4 x 10-12
96 Intracellular Signaling Peptides and Proteins 2.9 x 10-12
97 Chromosome Mapping 4.6 x 10-12
98 Reverse Transcriptase Polymerase Chain Reaction 1.1 x 10-11
99 Protein Isoforms 1.2 x 10-11
100 Vertebrates 1.3 x 10-11
101 Chordata 1.3 x 10-11
102 Organic Chemicals 1.5 x 10-11
103 Animals 1.6 x 10-11
104 Specialty Uses of Chemicals 2.3 x 10-11
105 Mammals 2.5 x 10-11
106 Breast Neoplasms 2.7 x 10-11
107 Chromosomes, Human, Pair 3 6.4 x 10-11
108 Digestive System Neoplasms 6.5 x 10-11
109 Breast Diseases 6.6 x 10-11
110 Physical Chromosome Mapping 1.4 x 10-10
111 Proto-Oncogene Proteins 1.4 x 10-10
112 Amino Acid Sequence 1.5 x 10-10
113 Transcriptional Activation 1.8 x 10-10
114 Head and Neck Neoplasms 1.9 x 10-10
115 Response Elements 2.1 x 10-10
116 Eukaryota 2.2 x 10-10
117 RNA, Neoplasm 2.5 x 10-10
118 Cell Proliferation 5.1 x 10-10
119 Enhancer Elements, Genetic 5.5 x 10-10
120 Cell Growth Processes 5.8 x 10-10
121 Nucleoproteins 6.2 x 10-10
122 Neoplasms, Squamous Cell 7.7 x 10-10
123 Adenocarcinoma 9.6 x 10-10
124 Transfection 1.4 x 10-9
125 DNA Primers 1.7 x 10-9
126 Basic-Leucine Zipper Transcription Factors 2.3 x 10-9
127 Restriction Mapping 2.6 x 10-9
128 Azacitidine 4.9 x 10-9
129 Histones 5.8 x 10-9
130 Urogenital Neoplasms 6.9 x 10-9
131 Receptors, Thyroid Hormone 9.2 x 10-9
132 Carcinoma, Hepatocellular 1.0 x 10-8
133 Gene Transfer Techniques 1.0 x 10-8
134 Oligodeoxyribonucleotides 1.1 x 10-8
135 Information Science 1.3 x 10-8
136 Recombination, Genetic 1.4 x 10-8
137 Cell Cycle Proteins 2.7 x 10-8
138 Apoptosis Regulatory Proteins 2.7 x 10-8
139 Histone Deacetylases 2.7 x 10-8
140 Leukemia, Promyelocytic, Acute 3.0 x 10-8
141 Chemical Actions and Uses 3.3 x 10-8
142 Chromosomes, Human, 1-3 3.4 x 10-8
143 Esophageal Neoplasms 3.6 x 10-8
144 Carcinoma, Squamous Cell 4.5 x 10-8
145 Ligands 5.8 x 10-8
146 Core Binding Factor Alpha 2 Subunit 8.3 x 10-8
147 DNA, Complementary 1.0 x 10-7
148 Open Reading Frames 1.0 x 10-7
149 Oligonucleotides 1.0 x 10-7
150 Transferases 1.1 x 10-7
151 Reading Frames 1.2 x 10-7
152 Oncogene Proteins, Fusion 1.4 x 10-7
153 Investigative Techniques 1.6 x 10-7
154 Mutant Chimeric Proteins 1.6 x 10-7
155 Chromosomes 3.0 x 10-7
156 DNA, Single-Stranded 3.2 x 10-7
157 Polynucleotides 3.5 x 10-7
158 Nucleic Acid Hybridization 3.7 x 10-7
159 Cell Cycle 4.4 x 10-7
160 Mutant Proteins 4.9 x 10-7
161 Neoplastic Processes 5.2 x 10-7
162 Core Binding Factor alpha Subunits 6.4 x 10-7
163 Acetylation 7.1 x 10-7
164 Core Binding Factors 7.3 x 10-7
165 Genetic Variation 7.4 x 10-7
166 Gene Library 7.6 x 10-7
167 Chromosomes, Human 7.7 x 10-7
168 Chromosomes, Mammalian 8.5 x 10-7
169 Receptors, Steroid 9.9 x 10-7
170 Gastrointestinal Neoplasms 1.0 x 10-6
171 Cell Differentiation 1.0 x 10-6
172 Retinoid X Receptor alpha 1.2 x 10-6
173 Protein Conformation 1.2 x 10-6
174 Respiratory Tract Neoplasms 1.2 x 10-6
175 Nuclear Receptor Co-Repressor 2 1.2 x 10-6
176 Calcium-Calmodulin-Dependent Protein Kinases 1.5 x 10-6
177 Exons 1.6 x 10-6
178 Lung Neoplasms 1.7 x 10-6
179 Cyclin-Dependent Kinase Inhibitor Proteins 1.7 x 10-6
180 Nuclear Receptor Subfamily 4, Group A, Member 2 1.9 x 10-6
181 Cyclin-Dependent Kinase Inhibitor p16 2.2 x 10-6
182 Liver Neoplasms 2.6 x 10-6
183 DNA Modification Methylases 2.6 x 10-6
184 Drug Resistance, Neoplasm 2.6 x 10-6
185 Leukemia, Myeloid 3.0 x 10-6
186 Protein Interaction Mapping 3.4 x 10-6
187 Cyclin D2 3.6 x 10-6
188 In Situ Hybridization 3.7 x 10-6
189 Acylation 4.0 x 10-6
190 Mutation 4.1 x 10-6
191 Growth 4.7 x 10-6
192 Enzymes 4.9 x 10-6
193 Retinol-Binding Proteins, Cellular 4.9 x 10-6
194 Cell Division 5.6 x 10-6
195 Orphan Nuclear Receptors 6.0 x 10-6
196 Fenretinide 6.3 x 10-6
197 Nuclear Receptor Coactivator 1 6.7 x 10-6
198 Cyclin D 7.9 x 10-6
199 Homeodomain Proteins 8.1 x 10-6
200 Transcription Factor AP-1 8.2 x 10-6
201 Genetic Code 8.2 x 10-6
202 Viral Proteins 8.2 x 10-6
203 Anticarcinogenic Agents 9.0 x 10-6
204 Apoptosis 9.2 x 10-6
205 Enzymes and Coenzymes 9.5 x 10-6
206 Binding Sites 1.0 x 10-5
207 Thoracic Neoplasms 1.1 x 10-5
208 Zinc Fingers 1.2 x 10-5
209 Co-Repressor Proteins 1.3 x 10-5
210 Loss of Heterozygosity 1.3 x 10-5
211 Uterine Neoplasms 1.4 x 10-5
212 Allelic Imbalance 1.4 x 10-5
213 Acetyltransferases 1.5 x 10-5
214 Two-Hybrid System Techniques 1.6 x 10-5
215 Histocytological Preparation Techniques 1.6 x 10-5
216 Staining and Labeling 1.8 x 10-5
217 Esophageal Diseases 1.9 x 10-5
218 Amino Acid Motifs 1.9 x 10-5
219 Molecular Conformation 2.0 x 10-5
220 Receptors, Glucocorticoid 2.1 x 10-5
221 Glutathione S-Transferase pi 2.3 x 10-5
222 Molecular Probe Techniques 2.4 x 10-5
223 Histological Techniques 2.5 x 10-5
224 Cytidine 2.8 x 10-5
225 Genital Neoplasms, Female 3.0 x 10-5
226 Acyltransferases 3.0 x 10-5
227 Cadherins 3.1 x 10-5
228 Nuclear Receptor Coactivators 3.1 x 10-5
229 Protein Structure, Secondary 3.3 x 10-5
230 Skin Diseases 3.6 x 10-5
231 Precancerous Conditions 3.8 x 10-5
232 Nucleotides 4.7 x 10-5
233 Prostatic Neoplasms 5.6 x 10-5
234 Recombinant Fusion Proteins 5.6 x 10-5
235 Amidohydrolases 5.9 x 10-5
236 Protein Binding 6.0 x 10-5
237 DNA (Cytosine-5-)-Methyltransferase 6.1 x 10-5
238 Leukemia, Myeloid, Acute 6.3 x 10-5
239 Biological Markers 6.3 x 10-5
240 Uterine Diseases 6.6 x 10-5
241 Gene Expression Regulation, Leukemic 6.8 x 10-5
242 Cell Nucleus 7.9 x 10-5
243 p300-CBP Transcription Factors 9.0 x 10-5
244 Hepatitis B virus 0.00010
245 Orthohepadnavirus 0.00010
246 DNA-Cytosine Methylases 0.00010
247 Trans-Activators 0.00011
248 Tumor Markers, Biological 0.00011
249 Cell Death 0.00011
250 Hepadnaviridae 0.00011
251 Cytogenetic Analysis 0.00011
252 Protein Structure, Tertiary 0.00012
253 Prostatic Diseases 0.00014
254 Pharmacological Phenomena 0.00015
255 Cyclins 0.00016
256 Retinol-Binding Proteins 0.00016
257 Signal Transduction 0.00017
258 Adaptor Proteins, Signal Transducing 0.00020
259 Phosphoproteins 0.00020
260 Computational Biology 0.00020
261 Histone Acetyltransferases 0.00021
262 Uterine Cervical Neoplasms 0.00021
263 Glutathione Transferase 0.00021
264 Viral Regulatory and Accessory Proteins 0.00022
265 Genital Neoplasms, Male 0.00023
266 Physiological Phenomena 0.00025
267 Lipodystrophy, Familial Partial 0.00025
268 Clinical Laboratory Techniques 0.00030
269 Digestive System Diseases 0.00030
270 Uterine Cervical Diseases 0.00032
271 Cell Transformation, Neoplastic 0.00033
272 Methyltransferases 0.00035
273 Endometrium 0.00036
274 Biopsy, Fine-Needle 0.00036
275 Skin and Connective Tissue Diseases 0.00038
276 Growth and Development 0.00038
277 Ribonucleosides 0.00041
278 Proto-Oncogene Proteins c-jun 0.00041
279 Sequence Analysis 0.00044
280 Phenotype 0.00045
281 Recombinant Proteins 0.00050
282 Alkyl and Aryl Transferases 0.00050
283 Polymorphism, Single Nucleotide 0.00051
284 Aza Compounds 0.00052
285 Breast 0.00052
286 Membrane Proteins 0.00053
287 Biochemistry 0.00055
288 Leukemia 0.00056
289 One-Carbon Group Transferases 0.00057
290 Thiazolidinediones 0.00064
291 Alleles 0.00066
292 Cytological Techniques 0.00066
293 Tumor Suppressor Protein p53 0.00067
294 Genomics 0.00070
295 Repressor Proteins 0.00071
296 Organic Chemistry Phenomena 0.00072
297 Propiophenones 0.00078
298 Peptides 0.00083
299 Heterochromatin 0.00088
300 DNA Restriction-Modification Enzymes 0.00089
301 Organic Chemistry Processes 0.00090
302 Myeloproliferative Disorders 0.00092
303 HL-60 Cells 0.00093
304 Neoplasm Metastasis 0.00093
305 Granulocyte Precursor Cells 0.00098
306 Proto-Oncogenes 0.0010
307 Sequence Homology 0.0011
308 Physiological Processes 0.0011
309 COUP Transcription Factor I 0.0012
310 Zebrafish 0.0012
311 Growth Differentiation Factor 15 0.0012
312 Insulin-Like Growth Factor Binding Protein 6 0.0012
313 Down-Regulation 0.0012
314 Cell Adhesion Molecules 0.0012
315 Repetitive Sequences, Nucleic Acid 0.0012
316 Cell Line, Transformed 0.0013
317 Genetic Markers 0.0013
318 GATA6 Transcription Factor 0.0014
319 Neoplasm Invasiveness 0.0016
320 Phosphotransferases (Alcohol Group Acceptor) 0.0016
321 Hepatitis Viruses 0.0017
322 RNA, Untranslated 0.0017
323 DNA, Intergenic 0.0017
324 Uterus 0.0018
325 Cell Aging 0.0018
326 Protein-Serine-Threonine Kinases 0.0018
327 Protein Biosynthesis 0.0019
328 Sequence Homology, Nucleic Acid 0.0019
329 Endometrial Neoplasms 0.0019
330 Up-Regulation 0.0020
331 Gene Expression Profiling 0.0021
332 Genital Diseases, Female 0.0021
333 Karyotyping 0.0021
334 Peptide Biosynthesis 0.0022
335 COUP Transcription Factors 0.0022
336 Retinal Pigment Epithelium 0.0023
337 Aldehyde Oxidoreductases 0.0023
338 Blotting, Northern 0.0023
339 Oncogenes 0.0023
340 Antimetabolites, Antineoplastic 0.0023
341 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 0.0024
342 Pyrimidine Nucleosides 0.0025
343 Transcription Factor TFIIIA 0.0025
344 Twist Transcription Factor 0.0025
345 Human papillomavirus 18 0.0026
346 Genome, Human 0.0026
347 Phosphotransferases 0.0028
348 Cytokines 0.0028
349 Nuclear Receptor Subfamily 4, Group A, Member 1 0.0028
350 Choroid Plexus Neoplasms 0.0029
351 Proteomics 0.0030
352 Kuru 0.0032
353 Sequence Analysis, DNA 0.0033
354 Cellular Structures 0.0034
355 Chromosome Structures 0.0034
356 Teratocarcinoma 0.0034
357 Gastrointestinal Diseases 0.0035
358 Sp3 Transcription Factor 0.0036
359 Tissue Inhibitor of Metalloproteinase-3 0.0037
360 Protein Kinases 0.0038
361 Microsatellite Instability 0.0039
362 Carcinoma, Small Cell 0.0039
363 Carcinoma, Renal Cell 0.0042
364 Hela Cells 0.0043
365 Transcription Factors, TFIII 0.0045
366 SOX9 Transcription Factor 0.0045
367 Drug Resistance 0.0046
368 Oxidoreductases Acting on Aldehyde or Oxo Group Donors 0.0046
369 Lamin Type A 0.0047
370 Chalcone 0.0047
371 RNA, Small Interfering 0.0048
372 Genetic Vectors 0.0048
373 Prostatic Intraepithelial Neoplasia 0.0052
374 Oncogene Proteins, Viral 0.0052
375 DNA Viruses 0.0053
376 Therapeutic Uses 0.0053
377 Liver Diseases 0.0054
378 Progeria 0.0055
379 Contig Mapping 0.0055
380 Bone Marrow Diseases 0.0056
381 Mammary Glands, Human 0.0057
382 Receptor, Platelet-Derived Growth Factor alpha 0.0057
383 Adenomatous Polyposis Coli Protein 0.0057
384 SOXE Transcription Factors 0.0058
385 Gene Knockdown Techniques 0.0059
386 Interferon Regulatory Factor-1 0.0060
387 Tetrahydronaphthalenes 0.0060
388 Adult Stem Cells 0.0061
389 Genotype 0.0063
390 Cyprinidae 0.0063
391 Genetics 0.0063
392 Von Hippel-Lindau Tumor Suppressor Protein 0.0064
393 Genetic Association Studies 0.0065
394 Genome-Wide Association Study 0.0065
395 Cypriniformes 0.0066
396 Introns 0.0066
397 Carcinoma, Adenosquamous 0.0067
398 Proto-Oncogene Proteins B-raf 0.0067
399 COS Cells 0.0068
400 Dinucleotide Repeats 0.0069
401 Pharyngeal Neoplasms 0.0070
402 Immunochemistry 0.0071
403 Controlled Clinical Trials as Topic 0.0072
404 Immunoblotting 0.0074
405 Respiratory Mucosa 0.0074
406 Chalcones 0.0077
407 DNA, Viral 0.0078
408 G0 Phase 0.0079
409 Microdissection 0.0079
410 Intercellular Signaling Peptides and Proteins 0.0080
411 Proto-Oncogene Proteins c-bcl-2 0.0081
412 Chondrogenesis 0.0081
413 Carcinoma, Endometrioid 0.0082
414 Tissue Scaffolds 0.0082
415 Ether-A-Go-Go Potassium Channels 0.0082
416 Adenovirus E1A Proteins 0.0083
417 Cluster Analysis 0.0083
418 Prostate 0.0084
419 Microsatellite Repeats 0.0085
420 Growth Differentiation Factors 0.0086
421 Genes, Reporter 0.0088
422 Chromatin Assembly and Disassembly 0.0088
423 Pathologic Processes 0.0094
424 Thrombomodulin 0.0094
425 DNA Packaging 0.0096
426 Lamins 0.0098
427 RNA, Antisense 0.0098
428 Genes, BRCA2 0.010
429 Osteocytes 0.010
430 Genes, jun 0.010
431 Bupropion 0.010
432 Alphapapillomavirus 0.010
433 Pharmacological Processes 0.010
434 Disease Progression 0.010
435 Protein Multimerization 0.010
436 Adenovirus E1 Proteins 0.011
437 Genital Diseases, Male 0.011
438 Genes, APC 0.011
439 In Situ Hybridization, Fluorescence 0.011
440 Blast Crisis 0.011
441 Aged, 80 and over 0.012
442 BRCA1 Protein 0.012
443 Nuclear Matrix-Associated Proteins 0.012
444 Receptors, Estrogen 0.013
445 Papua New Guinea 0.013
446 Multigene Family 0.013
447 Benzoates 0.013
448 Benzoic Acid 0.013
449 Exocrine Glands 0.013
450 Chemistry 0.014
451 Genes, bcl-2 0.014
452 Interferon Regulatory Factors 0.014
453 Intranuclear Space 0.014
454 Thyroid Neoplasms 0.014
455 Genes, Viral 0.015
456 Carcinoma, Lobular 0.015
457 Urologic Neoplasms 0.015
458 Endometrial Hyperplasia 0.015
459 SOX Transcription Factors 0.015
460 GATA Transcription Factors 0.015
461 Chromosomes, Human, X 0.015
462 STAT1 Transcription Factor 0.016
463 Biopsy 0.016
464 Leukoplakia, Oral 0.016
465 Cell Nucleus Structures 0.016
466 Metaplasia 0.016
467 Chromatin Immunoprecipitation 0.016
468 Chromatin 0.016
469 Interferon-Stimulated Gene Factor 3, alpha Subunit 0.016
470 Organ Specificity 0.016
471 TATA Box 0.016
472 Adaptor Proteins, Vesicular Transport 0.016
473 Tandem Repeat Sequences 0.017
474 Aldehyde Dehydrogenase 0.017
475 Adenovirus Early Proteins 0.017
476 Nucleosides 0.017
477 Interferon-Stimulated Gene Factor 3 0.018
478 Cerebral Ventricle Neoplasms 0.018
479 Biological Science Disciplines 0.018
480 Lipodystrophy 0.019
481 Esophagus 0.019
482 Genes, BRCA1 0.019
483 Blotting, Western 0.019
484 Sp1 Transcription Factor 0.019
485 Histology 0.020
486 Aged 0.020
487 Bronchial Neoplasms 0.020
488 Lung Diseases 0.020
489 Sp Transcription Factors 0.020
490 Oligonucleotide Array Sequence Analysis 0.021
491 Melanesia 0.021
492 Biology 0.022
493 U937 Cells 0.022
494 Receptors, Platelet-Derived Growth Factor 0.022
495 Monocyte-Macrophage Precursor Cells 0.022
496 Urogenital System 0.022
497 Hydrolases 0.022
498 Antisense Elements (Genetics) 0.022
499 Protective Agents 0.022
500 Nicotinic Agonists 0.022
501 Genitalia, Female 0.023
502 TGF-beta Superfamily Proteins 0.023
503 Choroid Plexus 0.023
504 Leukoplakia 0.023
505 Granulocyte-Macrophage Progenitor Cells 0.023
506 Genes, fos 0.023
507 Transglutaminases 0.023
508 Primary Myelofibrosis 0.024
509 Fluorescence Resonance Energy Transfer 0.024
510 Granulocytes 0.024
511 Gene Duplication 0.024
512 raf Kinases 0.024
513 Specimen Handling 0.024
514 Oropharyngeal Neoplasms 0.024
515 5' Untranslated Regions 0.025
516 Genome, Viral 0.026
517 Anatomy 0.026
518 Premenopause 0.026
519 Antidepressive Agents, Second-Generation 0.026
520 Biopsy, Needle 0.026
521 Culture Techniques 0.027
522 Neoplasm Transplantation 0.027
523 Antigens, CD44 0.027
524 Genomic Library 0.027
525 Sulfites 0.027
526 Transcription Factors, General 0.027
527 Linkage (Genetics) 0.028
528 Endodeoxyribonucleases 0.028
529 Exonucleases 0.028
530 Mesenchymal Stem Cells 0.028
531 Creutzfeldt-Jakob Syndrome 0.028
532 Cyclin D1 0.028
533 Brain Chemistry 0.029
534 Mutagenesis, Site-Directed 0.029
535 Genomic Instability 0.029
536 Genitalia 0.029
537 Mouth Neoplasms 0.030
538 Glutamate Dehydrogenase 0.030
539 Connective Tissue Cells 0.030
540 Forkhead Transcription Factors 0.030
541 Winged-Helix Transcription Factors 0.031
542 Laboratory Techniques and Procedures 0.031
543 Cyclooxygenase 2 Inhibitors 0.031
544 Tobacco Use Disorder 0.031
545 Receptors, Thrombin 0.031
546 Phosphatidylserines 0.031
547 Kidney Neoplasms 0.031
548 Epithelium 0.032
549 Nucleosomes 0.032
550 Glyceraldehyde-3-Phosphate Dehydrogenases 0.032
551 CCAAT-Enhancer-Binding Proteins 0.033
552 Cytodiagnosis 0.033
553 Early Diagnosis 0.033
554 Antimetabolites 0.033
555 Kruppel-Like Transcription Factors 0.034
556 Pharyngeal Diseases 0.034
557 Culture Media, Serum-Free 0.034
558 Potassium Channels, Voltage-Gated 0.035
559 Lac Operon 0.035
560 Molecular Epidemiology 0.035
561 Intracellular Space 0.035
562 Proto-Oncogene Proteins c-myc 0.036
563 Ovarian Neoplasms 0.036
564 Dissection 0.037
565 Databases, Protein 0.037
566 Genetic Predisposition to Disease 0.038
567 Prodrugs 0.038
568 Immunohistochemistry 0.038
569 Membrane Glycoproteins 0.038
570 Tissue Inhibitor of Metalloproteinases 0.039
571 Phenyl Ethers 0.039
572 DNA Topoisomerases, Type II 0.039
573 Antigens, Viral, Tumor 0.039
574 MAP Kinase Kinase Kinases 0.040
575 Telomerase 0.040
576 Immunologic Tests 0.040
577 Thymidine Kinase 0.040
578 Immunologic Techniques 0.041
579 Deoxyribonucleases 0.041
580 Deoxyribonuclease I 0.041
581 Bone Marrow Cells 0.041
582 Cyclin-Dependent Kinase Inhibitor p21 0.041
583 Lymphatic Metastasis 0.041
584 bcl-2-Associated X Protein 0.042
585 High Mobility Group Proteins 0.043
586 Chondrocytes 0.043
587 Fibroblasts 0.043
588 Polymorphism, Genetic 0.043
589 Hematopoietic System 0.043
590 Intestinal Neoplasms 0.043
591 Colonic Neoplasms 0.044
592 Databases as Topic 0.045
593 Thiazoles 0.045
594 Telomere 0.045
595 Insulin-Like Growth Factor Binding Proteins 0.046
596 Cholinergic Agonists 0.046
597 Prions 0.046
598 Untranslated Regions 0.047
599 Ki-67 Antigen 0.048
600 Gene Expression Regulation, Enzymologic 0.049
601 Gene Targeting 0.049
602 Otorhinolaryngologic Neoplasms 0.049
603 Chemoprevention 0.049
 5' Untranslated Regions   Acetylation   Adaptor Proteins, Vesicular Transport   Adenomatous Polyposis Coli Protein   Adenovirus E1A Proteins   Adult Stem Cells   Aged, 80 and over   Aldehyde Dehydrogenase   Alleles   Anticarcinogenic Agents   Antidepressive Agents, Second-Generation   Antigens, CD44   Antimetabolites, Antineoplastic   Apoptosis   Azacitidine   bcl-2-Associated X Protein   Benzoates   Biopsy, Fine-Needle   Blast Crisis   Blotting, Northern   Blotting, Western   Brain Chemistry   BRCA1 Protein   Breast Neoplasms   Bupropion   Cadherins   Calcium-Calmodulin-Dependent Protein Kinases   Carcinoma, Adenosquamous   Carcinoma, Endometrioid   Carcinoma, Hepatocellular   Carcinoma, Lobular   Carcinoma, Renal Cell   Carcinoma, Small Cell   Carcinoma, Squamous Cell   CCAAT-Enhancer-Binding Proteins   Cell Aging   Cell Differentiation   Chalcone   Chemoprevention   Chondrocytes   Chondrogenesis   Choroid Plexus   Choroid Plexus Neoplasms   Chromatin Assembly and Disassembly   Chromatin Immunoprecipitation   Chromosomes, Human, Pair 3   Chromosomes, Human, X   Cluster Analysis   Colonic Neoplasms   Contig Mapping   Core Binding Factor Alpha 2 Subunit   COS Cells   COUP Transcription Factor I   CpG Islands   Creutzfeldt-Jakob Syndrome   Culture Media, Serum-Free   Cyclin D1   Cyclin D2   Cyclin-Dependent Kinase Inhibitor p16   Cyclin-Dependent Kinase Inhibitor p21   Cyclooxygenase 2 Inhibitors   Databases, Protein   Deoxyribonuclease I   Dinucleotide Repeats   Disease Progression   DNA (Cytosine-5-)-Methyltransferase   DNA Methylation   DNA Primers   DNA Topoisomerases, Type II   DNA, Complementary   DNA, Neoplasm   DNA, Viral   Down-Regulation   Drug Resistance, Neoplasm   Early Diagnosis   Endometrial Hyperplasia   Endometrium   Esophageal Neoplasms   Esophagus   Ether-A-Go-Go Potassium Channels   Exons   Exonucleases   Fenretinide   Fluorescence Resonance Energy Transfer   Forkhead Transcription Factors   G0 Phase   GATA6 Transcription Factor   Gene Duplication   Gene Expression Profiling   Gene Expression Regulation, Leukemic   Gene Knockdown Techniques   Genes, APC   Genes, bcl-2   Genes, BRCA1   Genes, BRCA2   Genes, fos   Genes, jun   Genes, Reporter   Genes, Viral   Genetic Markers   Genetic Predisposition to Disease   Genetic Vectors   Genome, Human   Genome-Wide Association Study   Genomic Library   Glutamate Dehydrogenase   Glutathione S-Transferase pi   Glyceraldehyde-3-Phosphate Dehydrogenases   Growth Differentiation Factor 15   Hela Cells   Hepatitis B virus   Heterochromatin   Histone Deacetylases   Histones   HL-60 Cells   Homeodomain Proteins   Human papillomavirus 18   Humans   Immunochemistry   In Situ Hybridization, Fluorescence   Insulin-Like Growth Factor Binding Protein 6   Interferon Regulatory Factor-1   Introns   Karyotyping   Ki-67 Antigen   Kuru   Lac Operon   Lamin Type A   Leukemia, Promyelocytic, Acute   Leukoplakia, Oral   Ligands   Lipodystrophy, Familial Partial   Lymphatic Metastasis   Mammary Glands, Human   Mesenchymal Stem Cells   Metaplasia   Microdissection   Microsatellite Instability   Multigene Family   Mutagenesis, Site-Directed   Neoplasm Invasiveness   Neoplasm Transplantation   Nicotinic Agonists   Nuclear Receptor Co-Repressor 2   Nuclear Receptor Coactivator 1   Nuclear Receptor Subfamily 4, Group A, Member 1   Nuclear Receptor Subfamily 4, Group A, Member 2   Nucleosomes   Oncogene Proteins, Fusion   Open Reading Frames   Organ Specificity   Oropharyngeal Neoplasms   Osteocytes   p300-CBP Transcription Factors   Papua New Guinea   Phenyl Ethers   Phosphatidylserines   Polymorphism, Single Nucleotide   Premenopause   Primary Myelofibrosis   Prions   Prodrugs   Progeria   Prostate   Prostatic Intraepithelial Neoplasia   Prostatic Neoplasms   Protein Binding   Protein Isoforms   Protein Multimerization   Proteomics   Proto-Oncogene Proteins B-raf   Proto-Oncogene Proteins c-jun   Proto-Oncogene Proteins c-myc   Receptor, Platelet-Derived Growth Factor alpha   Receptors, Estrogen   Receptors, Glucocorticoid   Receptors, Thyroid Hormone   Recombinant Fusion Proteins   Respiratory Mucosa   Response Elements   Restriction Mapping   Retinal Pigment Epithelium   Retinoid X Receptor alpha   Retinol-Binding Proteins, Cellular   Reverse Transcriptase Polymerase Chain Reaction   RNA, Neoplasm   RNA, Small Interfering   Sequence Homology, Nucleic Acid   Signal Transduction   SOX9 Transcription Factor   Sp1 Transcription Factor   Sp3 Transcription Factor   STAT1 Transcription Factor   Sulfites   TATA Box   Telomerase   Telomere   Teratocarcinoma   Tetrahydronaphthalenes   Thiazolidinediones   Thrombomodulin   Thymidine Kinase   Thyroid Neoplasms   Tissue Inhibitor of Metalloproteinase-3   Tissue Scaffolds   Tobacco Use Disorder   Trans-Activators   Transcription Factor AP-1   Transcription Factor TFIIIA   Transcription, Genetic   Transcriptional Activation   Transfection   Transglutaminases   Tretinoin   Tumor Suppressor Protein p53   Twist Transcription Factor   Two-Hybrid System Techniques   U937 Cells   Up-Regulation   Uterine Cervical Neoplasms   Von Hippel-Lindau Tumor Suppressor Protein   Zebrafish   Zinc Fingers 
Brought to you by collaborators and the Wasserman Lab in Vancouver, Canada.
Cisreg.ca | CMMT | CFRI | UBC | Content subject to the Creative Commons Atribution-Share Alike 3.0 Unported License